Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Attachments

Busiest Mondays & Tuesdays YTD.xlsx

CreditFlow: Talking Point (€ IG Busiest Mondays & Tuesdays YTD)

IGC European Market: Commentary - General

€ IG Busiest Mondays & Tuesdays YTD


Tuesdays usually steal the show in € IG, but yesterday was a reminder that Mondays can still deliver. The session priced €10.65bn across 9 deals, the 3rd busiest Monday of 2026, & it did it without any help from SSA.


  • Yesterday’s mix: Corp & FIG did all the work
    • Corp: €5.7bn, led by Merck’s €3.7bn 4-tranche deal & Ametek’s €1.5bn
    • FIG: €4.95bn, with Nordea Mortgage Bank (€1.25bn covered), American Tower (€1.2bn) & Allianz (€1bn)
  • The Monday rankings: out of 35 Mondays with supply this year, only two have done more
    • 12 Jan: €24.65bn & 18 deals, with EFSF’s €7bn giving the year a flying start
    • 9 Feb: €12.15bn & 13 deals
    • Yesterday edges out 16 Mar (€10.5bn) & 2 Nov (€10.15bn, where Alphabet’s €6bn did most of the heavy lifting in just 3 deals).


€ IG

Busiest Mondays of 2026

Rank

Date

Corp (bn)

FIG (bn)

SSA (bn)

Total (bn)

# Deals

1

Mon 12-Jan

€ 5.35

€ 10.55

€ 8.75

€ 24.65

18

2

Mon 09-Feb

€ 3.65

€ 7.75

€ 0.75

€ 12.15

13

3

Mon 16-Nov

€ 5.70

€ 4.95

€ 0.00

€ 10.65

9

4

Mon 16-Mar

€ 3.60

€ 4.40

€ 2.50

€ 10.50

9

5

Mon 02-Nov

€ 6.65

€ 3.50

€ 0.00

€ 10.15

3


  • Well above the norm: the average Monday this year has been €6bn & 5.7 deals, so yesterday ran at c.1.8X normal volume
  • November’s Mondays: 2 of the year’s top 5 Mondays have now come this month, & the 9th of Nov (€9.25bn) only just missed out. Issuers are clearly keen to get ahead of the year-end slowdown

image.png

  • Tuesdays play in another league: the average Tuesday has been €12.9bn & 8.6 deals, roughly double a Monday. All of the top 5 cleared €26.75bn
    • #1 9 Jun: €44.95bn & 23 deals, led by Italy’s €18bn & the EU’s €8bn
    • #2 13 Jan: €32.3bn (EU €11bn & Greece €4bn)
    • #3 20 Jan: €28.55bn on just 8 deals (Spain €15bn & Morgan Stanley €5bn)
    • #4 19 May: €28.4bn & a year-high 24 deals. It’s also the most balanced day of the lot: Corp €8.05bn, FIG €10.6bn & SSA €9.75bn
    • #5 14 Apr: €26.75bn (France €10bn & EU €9bn)
  • SSA is the driver: SSA supplied c.62% of the top 5 Tuesdays’ volume (€99bn of €161bn). The year’s biggest days have been built on sovereign & EU syndications


€ IG

Busiest Tuesdays of 2026

Rank

Date

Corp (bn)

FIG (bn)

SSA (bn)

Total (bn)

# Deals

1

Tue 09-Jun

€ 6.20

€ 8.00

€ 30.75

€ 44.95

23

2

Tue 13-Jan

€ 0.00

€ 12.80

€ 19.50

€ 32.30

17

3

Tue 20-Jan

€ 3.05

€ 5.50

€ 20.00

€ 28.55

8

4

Tue 19-May

€ 8.05

€ 10.58

€ 9.75

€ 28.38

24

5

Tue 14-Apr

€ 5.00

€ 2.75

€ 19.00

€ 26.75

15


image.png

  • Yesterday shows the Corp & FIG pipeline is in rude health heading into the final stretch of the year
  • All three November Mondays have printed between €9.25bn & €10.65bn, an average of c.€10.0bn. That’s well above the €6bn average Monday this year. It’s also worth noting that this volume has come almost entirely from Corp & FIG rather than SSA. SSA is what powered the year’s biggest days, so this is real demand from the private sector, with multi-tranche Corp deals like Merck’s & Alphabet’s leading the way
  • With only a handful of windows left before the year-end slowdown, issuers clearly aren’t waiting for Tuesday to get deals done. Monday is earning its place as a genuine execution day rather than a warm-up
  • For today to join the Tuesday top 5, though, we’d need more than €26.75bn. Every Tuesday in that top 5 had at least €9.75bn of SSA, so breaking in looks like a tall order without a jumbo SSA print. Even so, another solid Corp & FIG session would keep November firmly on track as one of the busier months of the year
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.